The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Prospective study of acute HIV-1 infection in adults in East Africa and Thailand.
Open accessAbstract
BACKGROUND: Acute human immunodeficiency virus type 1 (HIV-1) infection is a major contributor to transmission of HIV-1. An understanding of acute HIV-1 infection may be important in the development of treatment strategies to eradicate HIV-1 or achieve a functional cure. METHODS: We performed twice-weekly qualitative plasma HIV-1 RNA nucleic acid testing in 2276 volunteers who were at high risk for HIV-1 infection. For participants in whom acute HIV-1 infection was detected, clinical observations, quantitative measurements of plasma HIV-1 RNA levels (to assess viremia) and HIV antibodies, and results of immunophenotyping of lymphocytes were obtained twice weekly. RESULTS: Fifty of 112 volunteers with acute HIV-1 infection had two or more blood samples collected before HIV-1 antibodies were detected. The median peak viremia (6.7 log10 copies per milliliter) occurred 13 days after the first sample showed reactivity on nucleic acid testing. Reactivity on an enzyme immunoassay occurred at a median of 14 days. The nadir of viremia (4.3 log10 copies per milliliter) occurred at a median of 31 days and was nearly equivalent to the viral-load set point, the steady-state viremia that persists durably after resolution of acute viremia (median plasma HIV-1 RNA level, 4.4 log10 copies per milliliter). The peak viremia and downslope were correlated with the viral-load set point. Clinical manifestations of acute HIV-1 infection were most common just before and at the time of peak viremia. A median of one symptom of acute HIV-1 infection was recorded at a median of two study visits, and a median of one sign of acute HIV-1 infection was recorded at a median of three visits. CONCLUSIONS: The viral-load set point occurred at a median of 31 days after the first detection of plasma viremia and correlated with peak viremia. Few symptoms and signs were observed during acute HIV-1 infection, and they were most common before peak viremia. (Funded by the Department of Defense and the National Institute of Allergy and Infectious Diseases.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Infection with HIV causes an acute but brief and nonspecific influenza-like retroviral syndrome that can include fever, malaise, lymphadenopathy, pharyngitis, arthritis, or skin rash.”
From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [408]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Most persons experience at least one symptom; however, some might be asymptomatic or have no recognition of illness (406–409).”
From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [408]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of HIV-1 infection with early antiretroviral therapy.
Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105243 · Cited by 6,873
Finzi, D., Blankson, J., Siliciano, J. D., Margolick, J. B., Chadwick, K., Pierson, T., Smith, K., Lisziewicz, J., Lori, F., Flexner, C., et al. (1999) · Nature Medicine · doi:10.1038/8394 · Cited by 2,119
Dynamics of HIV viremia and antibody seroconversion in plasma donors
Fiebig, E. W., Wright, D. J., Rawal, B. D., Garrett, P. E., Schumacher, R. T., Peddada, L., Heldebrant, C. M., Smith, R., Conrad, A. J., Kleinman, S. H., et al. (2003) · AIDS · doi:10.1097/00002030-200309050-00005 · Cited by 1,306
Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda.
Wawer, M. J., Gray, R. H., Sewankambo, N. K., Serwadda, D., Li, X., Laeyendecker, O., Kiwanuka, N., Kigozi, G., Kiddugavu, M., Lutalo, T., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/429411 · Cited by 1,258
Sáez‐Cirión, A., Bacchus, C., Hocqueloux, L., Avettand-Fènoël, V., Girault, I., Lécuroux, C., Potard, V., Versmisse, P., Mélard, A., Prazuck, T., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003211 · Cited by 1,012
Clinical and epidemiologic features of primary HIV infection.
Schacker, T., Collier, A. C., Hughes, J., Shea, T., & Corey, L. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-4-199608150-00001 · Cited by 703
Brief but Efficient: Acute HIV Infection and the Sexual Transmission of HIV
Pilcher, C. D., Tien, H. C., Eron, J. J., Vernazza, P., Leu, S., Stewart, P. W., Goh, L., & Cohen, M. S. (2004) · The Journal of Infectious Diseases · doi:10.1086/386333 · Cited by 663
High Rates of Forward Transmission Events after Acute/Early HIV‐1 Infection
BRENNER, B. G., Roger, M., Routy, J., Moisi, D. D., Ntemgwa, M. L., Matte, C., Baril, J.-G., Thomas, R., Rouleau, D., Bruneau, J., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/512088 · Cited by 637
Phenotypic properties of transmitted founder HIV-1
Parrish, N. F., Gao, F., Li, H., Giorgi, E. E., Barbian, H. J., Parrish, E. H., Zajic, L. B., Iyer, S. S., Decker, J. M., Kumar, A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304288110 · Cited by 422
Initial Plasma HIV-1 RNA Levels and Progression to AIDS in Women and Men
Sterling, T. R., Vlahov, D., Astemborski, J. A., Hoover, D. R., Margolick, J. B., & Quinn, T. C. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441003 · Cited by 357
Cited by
Sorted by citations
Sexually Transmitted Infections Treatment Guidelines, 2021
Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A. (2021) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7004a1 · Cited by 3,018
Sereti, I., Krebs, S. J., Phanuphak, N., Fletcher, J. L. K., Slike, B. M., Pinyakorn, S., O’Connell, R. J., Rupert, A. W., Chomont, N., Valcour, V., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw683 · Cited by 271
Self-citationAnanworanich, J., Chomont, N., Eller, L. A., Kroon, E. D. M. B., Tovanabutra, S., Bose, M., Nau, M. E., Fletcher, J. L. K., Tipsuk, S., Vandergeeten, C., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.07.024 · Cited by 239
Self-citationLi, H., Wang, S., Kong, R., Ding, W., Lee, F.-H., Parker, Z., Kim, E., Learn, G. H., Hahn, P., Policicchio, B., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1606636113 · Cited by 222
Jülg, B. D., Dee, L., Ananworanich, J., Barouch, D. H., Bar, K. J., Caskey, M. F., Colby, D. J., Dawson, L., Dong, K. L., Dubé, K., et al. (2019) · The Lancet HIV · doi:10.1016/s2352-3018(19)30052-9 · Cited by 201
Self-citation
Metadata
- Authors
- Robb, M. L., Eller, L. A., Kibuuka, H., Rono, K., Maganga, L., Nitayaphan, S., Kroon, E., Sawe, F. K., Sinei, S., Sriplienchan, S., Jagodzinski, L. L., Malia, J., Manak, M., de Souza, M. S., Tovanabutra, S., Sanders-Buell, E., Rolland, M., Dorsey-Spitz, J., Eller, M. A., Milazzo, M., Li, Q., Lewandowski, A., Wu, H., Swann, E., O’Connell, R. J., Peel, S., Dawson, P., Kim, J. H., & Michael, N. L.
- Affiliations
- Henry M. Jackson Foundation (US)
- Armed Forces Research Institute of Medical Science (TH)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2016-06-02
- Volume
- 374
- Issue
- 22
- Pages
- 2120-2130
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC5111628
- OpenAlex
- W2402980652
- Cited by
- 283
- References
- 39
- Citations by year
- 2026: 18 · 2025: 25 · 2024: 22 · 2023: 31 · 2022: 23 · 2021: 31 · 2020: 31 · 2019: 23 · 2018: 34 · 2017: 30 · 2016: 14
- FWCI
- 23.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (n01ai002642-013)
- National Institute of Allergy and Infectious Diseases (Y01 AI002642, Y1-AI-2642-17)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Keywords
- acute HIV-1 infection, HIV-1 viremia, viral load set point, HIV-1 viral load, HIV-1 antibodies, clinical symptoms and signs, HIV transmission, functional cure, East Africa, Thailand
- MeSH terms
- Adolescent, Adult, Africa, Eastern, Antibodies, Viral, Female, Humans, Male, Middle Aged, Prospective Studies, RNA, Viral, Thailand, Viremia, HIV-1, HIV Infections, Disease Progression, CD4 Lymphocyte Count, Viral Load
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
